At 9 am this morning, Dendreon Corporation (Nasdaq: DNDN) announced the long awaited interim analysis of the Phase 3, randomized, double-blind, placebo-controlled IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B). The clinical trial is designed to assess the safety and efficacy of the investigational active cellular immunotherapy Provenge® (sipuleucel-T) in men with metastatic [...]
Things are still good in kindergarten. Great actually. The Dev is loving every minute of his new school and honestly I can't blame him. The kids?seem to have the best time in that place. (I write that last sentence?as a jealous nine-to-five worker with four hour daily commute.) I asked him the other day what [...]
The Department of Urology at the Hospital São João in Portugal examined the intermediate-term outcome (up to 4 years) of a bone-anchored perineal sling (InVance(TM), produced by American Medical Systems, Minnetonka, MN, USA) in men with stress urinary incontinence (SUI) after prostate surgery. Sixty two men with SUI after prostate cancer surgery were given the [...]
Recent studies have raised a red flag of caution; it may not be wise also to be taking aspirin while on a hormone blockade (ADT). Recent findings show that for some men taking aspirin, which is commonly used in low daily doses for prevention of heart attack and stroke, may result in liver toxicity. Liver [...]
GTx, Inc. (Nasdaq: GTXI) has conducted a number of clinical trials using toremifene citrate in both the treatment of breast and prostate cancer. Older women and men as well as women and men being treated for both breast and prostate cancers are subject to bone loss leading to an increased risk of falls and fractures. [...]